KvaliMed - a Quality Project With Focus on Patients in Antipsychotic Treatment
NCT00750776 · Status: TERMINATED · Type: OBSERVATIONAL · Enrollment: 212
Last updated 2013-04-16
Summary
Rating and registration in KMS database of all patients in anti-psychotic treatment with 8 selected items from PANSS, GAF, 21 selected items from UKU, 3 selected items from TSQM. and measurement of compliance. Frequency of use of rating scales per participating health care professional.
Conditions
- Antipsychotic Treatment
- Quality Assurance
- Medical Treatment
Sponsors & Collaborators
- collaborator INDUSTRY
-
Psychiatric Centre Rigshospitalet
lead OTHER
Principal Investigators
-
Soren Blikenberg · Research Centre for Psychiatry Vordingborg
-
Michael Maagensen · Children Psychiatry Holbaek
-
Karin Byrsting · Odense University Hospital Odense C Psychiatric Hospital Slagelse
-
Marianne Jacoby · Outpatient TreatmentCopenhagen K
-
Peter Christoffersen · Psychiatric Hospital Slagelse
Eligibility
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2003-08-31
- Completion
- 2012-08-31
Countries
- Denmark
Study Locations
More Related Trials
-
15 Month Study for Adults Who Have Been Diagnosed With Schizophrenia and Incarcerated
NCT01157351 ·Status: COMPLETED ·Phase: PHASE4
-
A Comparative Study to Evaluate the Evolution of Medication Satisfaction and Adherence in Patients Unsatisfied With Current Oral Atypical Antipsychotics by Switching Medication to Paliperidone Palmitate
NCT01682161 ·Status: COMPLETED ·Phase: PHASE4
-
The Effect of Long-acting Antipsychotics on Schizophrenia Patients With Violence Risk
NCT04064476 ·Status: UNKNOWN
-
Parallel Group, Multiple Dose Pharmacokinetics Study of Five Antipsychotic Medications in Psychiatric Participants
NCT02087579 ·Status: COMPLETED ·Phase: PHASE1
-
A Study to Evaluate the Effectiveness and Safety of Paliperidone Palmitate in Subjects With Acute Schizophrenia
NCT01527305 ·Status: COMPLETED ·Phase: PHASE4
-
Twelve Month Study Comparing Paliperidone Palmitate and Select Oral Antipsychotics in Adults With Schizophrenia Who Have Been Recently Discharged From an Inpatient Psychiatric Hospital
NCT01193166 ·Status: WITHDRAWN ·Phase: PHASE4
-
A Study of Usage of Paliperidone Palmitate in Patients With Schizophrenia in a Hospital Setting
NCT01926912 ·Status: COMPLETED
-
A Study to Assess the Clinical Utility of Antipsychotic Medication Levels in Plasma as Determined by Liquid Chromatography-Tandem Mass Spectrometry
NCT02462473 ·Status: TERMINATED ·Phase: PHASE2
-
A Safety and Pharmacokinetic Study of Paliperidone Palmitate in Patients With Schizophrenia
NCT01150448 ·Status: COMPLETED ·Phase: PHASE1
-
Intramuscular Injections of Paliperidone Palmitate in the Arm or Buttock of Subjects With Schizophrenia
NCT00073320 ·Status: COMPLETED ·Phase: PHASE3
-
A Study to Analyze the Impact of Treatment With Paliperidone Palmitate on Clinical Outcomes and Hospital Resource Utilization in Adult Participants With Schizophrenia in Portugal
NCT03666715 ·Status: COMPLETED
-
Paliperidone Extended-Release (ER) Versus Risperidone for Neurocognitive Function in Patients With Schizophrenia
NCT00827840 ·Status: COMPLETED ·Phase: PHASE4
-
A Follow-Up Study of Schizophrenic Participants Following Treatment Discontinuation After Remission From a First Psychotic Episode
NCT00378092 ·Status: COMPLETED ·Phase: PHASE4
-
Non-Interventional Study of Participants With Newly Diagnosed Schizophrenia Treated With Paliperidone Palmitate
NCT02532842 ·Status: COMPLETED
-
A Study of Transition to the Paliperidone Palmitate 3-Month Formulation In Participants With Schizophrenia Previously Stabilized on the Paliperidone Palmitate 1-Month Formulation
NCT02713282 ·Status: COMPLETED ·Phase: PHASE3
-
A Study to Assess the Treatment of Schizophrenia With Paliperidone Palmitate in Rwandan Healthcare Settings
NCT04940039 ·Status: COMPLETED ·Phase: PHASE4
-
An Open-label Study to Assess the Long-term Safety, Tolerability, Effectiveness, and Durability of Effect of KarXT in Patients With DSM-5 Diagnosis of Schizophrenia
NCT05643170 ·Status: TERMINATED ·Phase: PHASE3
-
Open-label Study of Flexible-dose Paliperidone ER (Extended Release) to Treat Adolescent Schizophrenia.
NCT00488319 ·Status: COMPLETED ·Phase: PHASE3
-
European Long-acting Antipsychotics in Schizophrenia Trial
NCT02146547 ·Status: COMPLETED ·Phase: PHASE4
-
Paliperidone Palmitate Flexible Dosing in Schizophrenia
NCT01281527 ·Status: COMPLETED ·Phase: PHASE3
-
Efficacy and Safety of Paliperidone ER in First Episode Psychosis
NCT01157585 ·Status: COMPLETED ·Phase: PHASE4
-
IMPACT: A Study to Explore the Efficacy and Safety of Paliperidone ER in Patients With Acute Agitation
NCT01050478 ·Status: COMPLETED ·Phase: PHASE4
-
Flexible-dose Long-term Extension Study of Lu AF11167 in Patients With Schizophrenia With Prominent Negative Symptoms
NCT03929497 ·Status: TERMINATED ·Phase: PHASE2
-
Quality of Life (QOL) in Female Patient With Schizophrenia
NCT00498004 ·Status: TERMINATED ·Phase: PHASE4
-
Aripiprazole, Abilify Maintena Collaborative Clinical Protocol
NCT02717130 ·Status: TERMINATED ·Phase: NA